Logo image of ALIMP.PA

IMPLANET (ALIMP.PA) Stock Fundamental Analysis

EPA:ALIMP - Euronext Paris - Matif - FR0013470168 - Common Stock - Currency: EUR

0.114  0 (-1.3%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ALIMP. ALIMP was compared to 55 industry peers in the Health Care Equipment & Supplies industry. ALIMP may be in some trouble as it scores bad on both profitability and health. ALIMP does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALIMP has reported negative net income.
ALIMP had a negative operating cash flow in the past year.
ALIMP had negative earnings in each of the past 5 years.
In the past 5 years ALIMP always reported negative operating cash flow.
ALIMP.PA Yearly Net Income VS EBIT VS OCF VS FCFALIMP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -2M -4M -6M -8M

1.2 Ratios

ALIMP has a worse Return On Assets (-45.44%) than 85.45% of its industry peers.
ALIMP has a Return On Equity of -172.99%. This is amonst the worse of the industry: ALIMP underperforms 81.82% of its industry peers.
Industry RankSector Rank
ROA -45.44%
ROE -172.99%
ROIC N/A
ROA(3y)-35.23%
ROA(5y)-37.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALIMP.PA Yearly ROA, ROE, ROICALIMP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1K 2K 3K

1.3 Margins

ALIMP's Gross Margin of 55.22% is in line compared to the rest of the industry. ALIMP outperforms 49.09% of its industry peers.
In the last couple of years the Gross Margin of ALIMP has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for ALIMP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.67%
GM growth 5Y0.45%
ALIMP.PA Yearly Profit, Operating, Gross MarginsALIMP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100

More info and screens

1

2. Health

2.1 Basic Checks

ALIMP does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALIMP has more shares outstanding
Compared to 5 years ago, ALIMP has more shares outstanding
Compared to 1 year ago, ALIMP has a worse debt to assets ratio.
ALIMP.PA Yearly Shares OutstandingALIMP.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
ALIMP.PA Yearly Total Debt VS Total AssetsALIMP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

2.2 Solvency

ALIMP has an Altman-Z score of -0.56. This is a bad value and indicates that ALIMP is not financially healthy and even has some risk of bankruptcy.
ALIMP has a Altman-Z score of -0.56. This is in the lower half of the industry: ALIMP underperforms 70.91% of its industry peers.
ALIMP has a Debt/Equity ratio of 0.72. This is a neutral value indicating ALIMP is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.72, ALIMP is doing worse than 72.73% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF N/A
Altman-Z -0.56
ROIC/WACCN/A
WACC5.76%
ALIMP.PA Yearly LT Debt VS Equity VS FCFALIMP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M

2.3 Liquidity

ALIMP has a Current Ratio of 1.17. This is a normal value and indicates that ALIMP is financially healthy and should not expect problems in meeting its short term obligations.
ALIMP has a Current ratio of 1.17. This is in the lower half of the industry: ALIMP underperforms 65.45% of its industry peers.
ALIMP has a Quick Ratio of 1.17. This is a bad value and indicates that ALIMP is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.59, ALIMP is doing worse than 81.82% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 0.59
ALIMP.PA Yearly Current Assets VS Current LiabilitesALIMP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

ALIMP shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.27%.
ALIMP shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.85%.
ALIMP shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.08% yearly.
EPS 1Y (TTM)-6.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.23%
Revenue 1Y (TTM)-10.85%
Revenue growth 3Y24.15%
Revenue growth 5Y2.08%
Sales Q2Q%-3.54%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALIMP.PA Yearly Revenue VS EstimatesALIMP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
ALIMP.PA Yearly EPS VS EstimatesALIMP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 -10 -20 -30 -40

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALIMP. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALIMP.PA Price Earnings VS Forward Price EarningsALIMP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALIMP.PA Per share dataALIMP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALIMP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IMPLANET

EPA:ALIMP (3/7/2025, 7:00:00 PM)

0.114

0 (-1.3%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap14.25M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.95
P/FCF N/A
P/OCF N/A
P/B 4.07
P/tB 26.43
EV/EBITDA N/A
EPS(TTM)-0.13
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.06
BVpS0.03
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -45.44%
ROE -172.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 55.22%
FCFM N/A
ROA(3y)-35.23%
ROA(5y)-37.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.67%
GM growth 5Y0.45%
F-Score3
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 10.57%
Cap/Sales 4.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.17
Quick Ratio 0.59
Altman-Z -0.56
F-Score3
WACC5.76%
ROIC/WACCN/A
Cap/Depr(3y)12.17%
Cap/Depr(5y)13.92%
Cap/Sales(3y)2.98%
Cap/Sales(5y)2.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.23%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-10.85%
Revenue growth 3Y24.15%
Revenue growth 5Y2.08%
Sales Q2Q%-3.54%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-63.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-36.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-35.2%
OCF growth 3YN/A
OCF growth 5YN/A